EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Association of IFN ‐γ +874 T/A Polymorphism With COVID ‐19 Susceptibility, Severity, and Inflammatory Response: A Case–Control Study From Southern Iran

Nasir Arefinia iD, Bahman Aghcheli iD, Seyed Mohammad Ali Hashemi, Zohreh-Al-Sadat Ghoreshi, Emad Behboudi iD

Journal of Clinical Laboratory Analysis · 2026

DOI: 10.1002/jcla.70362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2026. Verfasst von Nasir Arefinia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bio Environmental Health Hazards Research Center, Jiroft University of Medical Sciences, Jiroft, Iran. Hauptthemen laut MEDLINE: Interferon-gamma, COVID-19, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Significant interpatient variability in Coronavirus Disease 2019 (COVID‐19) manifestations highlights the influence of host genetic factors on disease outcomes. This study examines its association with COVID‐19 susceptibility, severity, and inflammatory markers in an Iranian population.

Methods

A retrospective case–control analysis was performed on 210 COVID‐19 patients and 210 age‐ and sex‐matched control subjects to evaluate whether the Interferon‐gamma (IFN‐γ) gene polymorphism (+874 T/A) is associated with disease severity.

Results

Patients had more comorbidities (e.g., diabetes 26.2% vs. 14.3%; hypertension 29.5% vs. 16.7%) and pronounced paraclinical abnormalities, including elevated Neutrophil‐to‐Lymphocyte Ratio (NLR) (8.1 vs. 1.9), C‐reactive protein (CRP) (45.5 vs. 3.2 mg/L), and lymphopenia (1.1 vs. 2.1 × 10 3 /μL; all p < 0.001). The TA genotype and A allele increased disease susceptibility (Odds Ratio (OR) =2.05 (95% CI: 1.32–3.19), p = 0.002; OR = 1.58 (95% CI: 1.11–2.25), p = 0.01, respectively). The TA genotype independently predicted severe disease (aOR = 2.85, p = 0.001), and both the TA and AA genotypes were linked to higher IL‐6 levels ( p < 0.001). TT carriers had shorter hospitalizations ( p < 0.01). Combining TA/AA with NLR improved severity prediction (AUC = 0.82 (95% CI: 0.76–0.88)).

Conclusion

The IFN‐γ +874 TA genotype was independently associated with severe COVID‐19. The TA genotype appears to confer increased risk of severe disease, whereas the AA genotype may be linked to a milder clinical presentation despite elevated inflammatory markers. Integration of genetic and hematological parameters may enhance risk stratification; however, further validation in larger and diverse populations is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon-gammaCOVID-19Genetic Predisposition to DiseasePolymorphism, Single NucleotideInflammationPneumonia, ViralCoronavirus InfectionsHumansIranFemaleCase-Control StudiesMaleMiddle AgedRetrospective StudiesSeverity of Illness IndexSARS-CoV-2AdultGenotypeAged

Stichwörter der Autor:innen

COVID‐19IFN‐γclinical outcomedisease severityhost geneticsinterleukin‐6

Substanzen

Interferon-gamma

Autor:innen und Institutionen

  • Bio Environmental Health Hazards Research Center, Jiroft University of Medical Sciences, Jiroft, Iran.
  • Infectious Disease Research Center, Gonabad University of Medical Sciences, Gonabad, Iran.
  • Department of Bacteriology & Virology, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Faculty of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran.
  • Department of Basic Medical Sciences, Khoy University of Medical Sciences, Khoy, Iran.

ORCID-Profile: Nasir Arefinia, Bahman Aghcheli, Emad Behboudi

Zitieren

APA

Arefinia, N., Aghcheli, B., Hashemi, S. M. A., Ghoreshi, Z. A., & Behboudi, E. (2026). Association of IFN ‐γ +874 T/A Polymorphism With COVID ‐19 Susceptibility, Severity, and Inflammatory Response: A Case–Control Study From Southern Iran. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70362

Vancouver

Arefinia N, Aghcheli B, Hashemi SMA, Ghoreshi ZA, Behboudi E. Association of IFN ‐γ +874 T/A Polymorphism With COVID ‐19 Susceptibility, Severity, and Inflammatory Response: A Case–Control Study From Southern Iran. Journal of Clinical Laboratory Analysis. 2026. doi:10.1002/jcla.70362

BibTeX
@article{Arefinia2026,
  author = {Arefinia, Nasir and Aghcheli, Bahman and Hashemi, Seyed Mohammad Ali and Ghoreshi, Zohreh-Al-Sadat and Behboudi, Emad},
  title = {Association of IFN ‐γ +874 T/A Polymorphism With COVID ‐19 Susceptibility, Severity, and Inflammatory Response: A Case–Control Study From Southern Iran},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2026},
  doi = {10.1002/jcla.70362}
}
Kostenlos starten →